#119: Stents, ICDs, inappropriate? Then CMS won't pay; FDA investigating serious bleeding events with dabigatran; Generic atorvastatin now in US; CV risk negligible with COX-2 inhibitors but AF a possible concern; noncardiac chest pain

Stents, ICDs, inappropriate? Then CMS won't pay; FDA investigating serious bleeding events with dabigatran; Generic atorvastatin now in US; CV risk negligible with COX-2 inhibitors but AF a possible concern; noncardiac chest pain

Source: Radio TheHeart.org - December 9, 2011 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts